↓ Skip to main content

Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes

Overview of attention for article published in BMC Cancer, October 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
21 Mendeley
Title
Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes
Published in
BMC Cancer, October 2014
DOI 10.1186/1471-2407-14-772
Pubmed ID
Authors

Ying Tian, Eri Arai, Masahiro Gotoh, Motokiyo Komiyama, Hiroyuki Fujimoto, Yae Kanai

Abstract

The CpG island methylator phenotype (CIMP) of clear cell renal cell carcinomas (ccRCCs) is characterized by accumulation of DNA methylation at CpG islands and poorer patient outcome. The aim of this study was to establish criteria for prognostication of patients with ccRCCs using the ccRCC-specific CIMP marker genes.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 33%
Student > Ph. D. Student 3 14%
Other 3 14%
Student > Doctoral Student 2 10%
Student > Postgraduate 1 5%
Other 5 24%
Readers by discipline Count As %
Medicine and Dentistry 10 48%
Biochemistry, Genetics and Molecular Biology 4 19%
Agricultural and Biological Sciences 4 19%
Computer Science 1 5%
Decision Sciences 1 5%
Other 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2014.
All research outputs
#8,978,850
of 11,234,828 outputs
Outputs from BMC Cancer
#2,742
of 4,151 outputs
Outputs of similar age
#141,137
of 209,630 outputs
Outputs of similar age from BMC Cancer
#114
of 167 outputs
Altmetric has tracked 11,234,828 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,151 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,630 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.